January 20, 2017
NPhA Chairman Masaru Nakamura The Nippon Pharmacy Association (NPhA) will be strongly instructing its member companies to take caution in drug purchases after counterfeit versions of Gilead Sciences’s hepatitis C med Harvoni (ledipasvir + sofosbuvir) were found in Japan, Chairman...read more